Martina S. Rauner

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 217 publications

Erratum: [Corrigendum] Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro.

Erratum: [Corrigendum] Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro.

Journal: Oncology letters
Published: June 22, 2026

Deconstructing senescence phenotypes in cells of the bone and bone marrow.

Deconstructing senescence phenotypes in cells of the bone and bone marrow.

Journal: The Journal of clinical investigation
Published: April 01, 2026

1-Phosphatidylinositol 3-Phosphate 5-Kinase Inhibition by Apilimod Promotes an Adipocyte-Like Vascular Smooth Muscle Cell Phenotype and Prevents Arterial Calcification.

1-Phosphatidylinositol 3-Phosphate 5-Kinase Inhibition by Apilimod Promotes an Adipocyte-Like Vascular Smooth Muscle Cell Phenotype and Prevents Arterial Calcification.

Journal: Circulation research
Published: January 14, 2026

Thra knockout protects male mice from hyperthyroidism-driven cortical bone loss by mitigating bone resorption.

Thra knockout protects male mice from hyperthyroidism-driven cortical bone loss by mitigating bone resorption.

Journal: JBMR plus
Published: November 12, 2025

Mechanisms of osteoclast activation in inflammatory bone loss in rheumatoid arthritis.

Mechanisms of osteoclast activation in inflammatory bone loss in rheumatoid arthritis.

Journal: Nature reviews. Rheumatology
Published: October 22, 2025

Diagnosis and management of diabetes and co-existing osteoporosis (Update 2026)

Diagnosis and management of diabetes and co-existing osteoporosis (Update 2026)

Journal: Wiener klinische Wochenschrift
Published: October 06, 2025

Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss.

Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss.

Journal: HemaSphere
Published: September 01, 2025

Increased fracture risk associated with iron-deficiency anemia: a population-based propensity score matched cohort study.

Increased fracture risk associated with iron-deficiency anemia: a population-based propensity score matched cohort study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: August 13, 2025

Iron overload induced by ferric derisomaltose and ferric carboxymaltose both increase FGF-23 levels and lead to osteomalacia and bone loss in normal mice.

Iron overload induced by ferric derisomaltose and ferric carboxymaltose both increase FGF-23 levels and lead to osteomalacia and bone loss in normal mice.

Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Published: July 04, 2025

Iron and Bone Pathophysiology.

Iron and Bone Pathophysiology.

Journal: Advances in experimental medicine and biology
Published: July 02, 2025

Glucocorticoid-induced osteoporosis: novel concepts and clinical implications.

Glucocorticoid-induced osteoporosis: novel concepts and clinical implications.

Journal: The lancet. Diabetes & endocrinology
Published: June 30, 2025

Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement.

Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement.

Journal: Journal of clinical medicine
Published: May 17, 2025
Showing 1-12 of 217

Last Updated: 09/26/2026